The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis

The Mycobacterium tuberculosis fatty acid synthase type II (FAS-II) system has the unique property of producing unusually long-chain fatty acids involved in the biosynthesis of mycolic acids, key molecules of the tubercle bacillus. The enzyme(s) responsible for dehydration of (3R)-hydroxyacyl-ACP during the elongation cycles of the mycobacterial FAS-II remained unknown. This step is classically catalyzed by FabZ- and FabA-type enzymes in bacteria, but no such proteins are present in mycobacteria. Bioinformatic analyses and an essentiality study allowed the identification of a candidate protein cluster, Rv0635-Rv0636-Rv0637. Its expression in recombinant Escherichia coli strains leads to the formation of two heterodimers, Rv0635-Rv0636 (HadAB) and Rv0636-Rv0637 (HadBC), which also occurs in Mycobacterium smegmatis, as shown by split-Trp assays. Both heterodimers exhibit the enzymatic properties expected for mycobacterial FAS-II dehydratases: a marked specificity for both long-chain (≥C12) and ACP-linked substrates. Furthermore, they function as 3-hydroxyacyl dehydratases when coupled with MabA and InhA enzymes from the M. tuberculosis FAS-II system. HadAB and HadBC are the long-sought (3R)-hydroxyacyl-ACP dehydratases. The correlation between the substrate specificities of these enzymes, the organization of the orthologous gene cluster in different Corynebacterineae, and the structure of their mycolic acids suggests distinct roles for both heterodimers during the elongation process. This work describes bacterial monofunctional (3R)-hydroxyacyl-ACP dehydratases belonging to the hydratase 2 family. Their original structure and the fact that they are essential for M. tuberculosis survival make these enzymes very good candidates for the development of antimycobacterial drugs.

[1]  C. Rock,et al.  Preparative enzymatic synthesis and hydrophobic chromatography of acyl-acyl carrier protein. , 1979, The Journal of biological chemistry.

[2]  R. Slayden,et al.  Mycolic acids: structure, biosynthesis and physiological functions. , 1998, Progress in lipid research.

[3]  C. Rock,et al.  Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. , 1996, Biochimica et biophysica acta.

[4]  P. Johansson,et al.  Structure and function of Rv0130, a conserved hypothetical protein from Mycobacterium tuberculosis , 2006, Protein science : a publication of the Protein Society.

[5]  Gurdyal S Besra,et al.  Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. , 2002, The Biochemical journal.

[6]  D. Zerbib,et al.  Rv3389C from Mycobacterium tuberculosis, a member of the (R)-specific hydratase/dehydratase family. , 2007, Biochimica et biophysica acta.

[7]  J. Hiltunen,et al.  A Two-domain Structure of One Subunit Explains Unique Features of Eukaryotic Hydratase 2* , 2004, Journal of Biological Chemistry.

[8]  L. Kremer,et al.  Conditional Depletion of KasA, a Key Enzyme of Mycolic Acid Biosynthesis, Leads to Mycobacterial Cell Lysis , 2005, Journal of bacteriology.

[9]  Xavier Charpentier,et al.  MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II. , 2002, Microbiology.

[10]  G. Besra,et al.  Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice , 2007, Proceedings of the National Academy of Sciences.

[11]  C. Volker,et al.  Purification and Biochemical Characterization of theMycobacterium tuberculosis β-Ketoacyl-acyl Carrier Protein Synthases KasA and KasB* , 2001, The Journal of Biological Chemistry.

[12]  J C Sacchettini,et al.  Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. , 1995, Biochemistry.

[13]  E. Brown,et al.  Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy , 2003, Molecular microbiology.

[14]  C. Dye,et al.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[15]  A. Joshi,et al.  Construction, expression, and characterization of a mutated animal fatty acid synthase deficient in the dehydrase function. , 1993, The Journal of biological chemistry.

[16]  J. Hiltunen,et al.  Human Peroxisomal Multifunctional Enzyme Type 2 , 2000, The Journal of Biological Chemistry.

[17]  James C. Sacchettini,et al.  Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis , 2000, Journal of bacteriology.

[18]  N. Johnsson,et al.  Transforming a (β/α)8-Barrel Enzyme into a Split-Protein Sensor through Directed Evolution , 2004 .

[19]  T. Parish,et al.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. , 2000, Microbiology.

[20]  T. Unge,et al.  Rv0216, a conserved hypothetical protein from Mycobacterium tuberculosis that is essential for bacterial survival during infection, has a double hotdog fold , 2005, Protein science : a publication of the Protein Society.

[21]  K. Autio,et al.  Htd2p/Yhr067p is a yeast 3‐hydroxyacyl‐ACP dehydratase essential for mitochondrial function and morphology , 2004, Molecular microbiology.

[22]  T. Fukui,et al.  Crystal Structure of the (R)-Specific Enoyl-CoA Hydratase from Aeromonas caviae Involved in Polyhydroxyalkanoate Biosynthesis* , 2003, The Journal of Biological Chemistry.

[23]  T. Parish,et al.  Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG , 2007, Journal of bacteriology.

[24]  I. Smith,et al.  Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice , 2000, Molecular microbiology.

[25]  K. Bloch Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. , 2006, Advances in enzymology and related areas of molecular biology.

[26]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.